Jackson Laboratory Cancer Center scientists are combining human cancer genomics with mouse biology and genetics expertise to interrogate cancer in clinically meaningful ways.
Karolina Palucka, M.D., Ph.D., professor and associate director of cancer immunology at The Jackson Laboratory (JAX), was among the honorees at the Connecticut Technology Council’s 12th Annual Women of Innovation Awards Gala in Plantsville, Conn., on April 6.
Jackson Laboratory (JAX) cancer researcher Carol Bult, Ph.D., has been appointed to the Knowlton Family Chair, an endowed professorship newly established by Winthrop Knowlton, chairman emeritus of the Laboratory’s board of trustees.
Professor Karolina Palucka, M.D., received an RO1 grant award for “Humanized mouse models to dissect in vivo the interplay between melanoma and the immune system."
Research team led by JAX CEO Edison Liu has found the molecular fingerprint — and a potential therapy — for some of the deadliest cancers affecting women.
Cyteir is leveraging its expertise in DNA repair and genome instability to develop new targeted therapeutics for cancer, autoimmune disorders and more.
The Jackson Laboratory Cancer Center has once again earned the renewal of its Cancer Center Support Grant from the National Cancer Institute (NCI).
The JAXCC encompasses three campuses: the headquarters and research campus in Bar Harbor, Maine, a genomics research campus in Farmington, Conn., and a facility in Sacramento, Calif specializing in preclinical model development, credentialing, and deployment in pre-and co-clinical trials.
The Bar Harbor faculty has deep expertise in mouse biology, complex genetics and computational biology that informs new experimental platforms including genetically defined mouse models bearing humanized disease alleles; improved mouse hosts for patient-derived xenografts (PDX); and novel mouse populations that model the genetic variation of human populations.
The Farmington faculty is expert in human cancer genomics; genome biology; quantitative cell biology; and computational biology and analytics, all centered on developing approaches to precision medicine.
The Sacramento campus has established a large, collaborative resource of PDX models as a major preclinical platform.